Answers are grounded in this paper and cite their sources.
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.
No takes yet. Share an insight, caveat, or question.
Garland et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: